The initial studies towards exploring the radioprotective activity of DSePA were carried out using in vitro models
Popular treatments approved by the FDA include Sales for Lillys GLP-1 treatments reached $40 billion in 2025, accounting for 62% of the companys annual revenue
The Company announced the proposal publicly on January 13, 2026, covering Arizona, Florida, Hawaii, Illinois, Maryland, South Carolina, Virginia, and Washington, D.C
Sarepta does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof, except as required by law
For those requiring supplements, cyanocobalamin and hydroxocobalamin are both effective forms available in the UK, with hydroxocobalamin preferred for injections due to superior tissue retention, as noted in the British National Formulary